EZH2 overexpression or gain-of-function mutations are frequently seen in high-grade follicular lymphoma, DLBCL, Burkitt lymphoma, natural killer/T-cell (NKT) lymphoma [21], and 4;14 translocation MM patients [13,22,23]. This evidence concerns the gene EZH2 and follicular lymphoma.